Search Results

Filter
  • 1-10 of  25 results for ""HIV-associated lipodystrophy syndrome""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Subjective clinical lipoatrophy assessment correlates with DEXA-measured limb fat.

  • Authors : Tungsiripat M; Department of Infectious Diseases, Cleveland Clinic Foundation, Cleveland, Ohio, USA.; O'Riordan MA

Subjects: Absorptiometry, Photon*; Extremities/Extremities/Extremities/*diagnostic imaging ; HIV-Associated Lipodystrophy Syndrome/HIV-Associated Lipodystrophy Syndrome/HIV-Associated Lipodystrophy Syndrome/*diagnosis

  • Source: HIV clinical trials [HIV Clin Trials] 2009 Sep-Oct; Vol. 10 (5), pp. 314-9.Publisher: Taylor & Francis Country of Publication: England NLM ID: 100936377 Publication Model: Print Cited Medium: Print ISSN: 1528-4336

Record details

×
Academic Journal

Objective assessment of facial lipoatrophy changes in a cohort of HIV-infected patients taking combination antiretroviral therapy.

  • Authors : Yang Y; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore.; Yap M

Subjects: Face* ; Lasers*; Adipose Tissue/Adipose Tissue/Adipose Tissue/*pathology

  • Source: HIV clinical trials [HIV Clin Trials] 2008 Nov-Dec; Vol. 9 (6), pp. 399-406.Publisher: Taylor & Francis Country of Publication: England NLM ID: 100936377 Publication Model: Print Cited Medium: Print ISSN: 1528-4336

Record details

×
Academic Journal

Improvements in subcutaneous fat, lipid profile, and parameters of mitochondrial toxicity in patients with peripheral lipoatrophy when stavudine is switched to tenofovir (LIPOTEST study).

  • Authors : Ribera E; Department of Infectious Diseases, Hospital Universitari Vall d'Hebron, Barcelona, Spain. ; Paradiñeiro JC

Subjects: Adenine/Adenine/Adenine/*analogs & derivatives ; Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*therapeutic use ; HIV Infections/HIV Infections/HIV Infections/*drug therapy

  • Source: HIV clinical trials [HIV Clin Trials] 2008 Nov-Dec; Vol. 9 (6), pp. 407-17.Publisher: Taylor & Francis Country of Publication: England NLM ID: 100936377 Publication Model: Print Cited Medium: Print ISSN: 1528-4336

Record details

×
Academic Journal

Multidisciplinary approach to the treatment of metabolic and morphologic alterations of HIV-related lipodystrophy.

  • Authors : Guaraldi G; Department of Medicine and Medical Specialties, Infectious Diseases Clinic, University of Modena and Reggio Emilia, Via del Pozzo 71, 41100 Modena, Italy. ; Orlando G

Subjects: Counseling* ; Exercise* ; Feeding Behavior*

  • Source: HIV clinical trials [HIV Clin Trials] 2006 May-Jun; Vol. 7 (3), pp. 97-106.Publisher: Taylor & Francis Country of Publication: England NLM ID: 100936377 Publication Model: Print Cited Medium: Print ISSN: 1528-4336

Record details

×
Academic Journal

Changes in body fat measured by DEXA in patients taking different formulations of stavudine.

  • Authors : Yang Y; Infectious Disease Research Centre, Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore.; Wilder-Smith A

Subjects: HIV Infections/HIV Infections/HIV Infections/*drug therapy ; HIV-1/HIV-1/HIV-1/*growth & development ; HIV-Associated Lipodystrophy Syndrome/HIV-Associated Lipodystrophy Syndrome/HIV-Associated Lipodystrophy Syndrome/*chemically induced

  • Source: HIV clinical trials [HIV Clin Trials] 2005 Nov-Dec; Vol. 6 (6), pp. 337-43.Publisher: Taylor & Francis Country of Publication: England NLM ID: 100936377 Publication Model: Print Cited Medium: Print ISSN: 1528-4336

Record details

×
Academic Journal

A randomized, double-blind, placebo-controlled study of benfluorex in HIV-infected patients with insulin resistance or impaired glucose tolerance.

  • Authors : Poizot-Martin I; CISIH-SUD Clinical Research Department, Pôle Oncologie Spécialités Médicales et Chirurgicales, CHU Sainte-Marguerite, APHM, Marseille, France. ; Drogoul-Vey MP

Subjects: HIV-1* ; Insulin Resistance*; Fenfluramine/Fenfluramine/Fenfluramine/*analogs & derivatives

  • Source: HIV clinical trials [HIV Clin Trials] 2009 Jan-Feb; Vol. 10 (1), pp. 33-40.Publisher: Taylor & Francis Country of Publication: England NLM ID: 100936377 Publication Model: Print Cited Medium: Print ISSN: 1528-4336

Record details

×
Academic Journal

A prospective study of body fat redistribution, lipid, and glucose parameters in HIV-infected patients initiating combination antiretroviral therapy.

  • Authors : Walmsley S; Department of Medicine, University Health Network, Toronto, Ontario, Canada. ; Cheung AM

Subjects: Adipose Tissue/Adipose Tissue/Adipose Tissue/*drug effects ; Anti-Retroviral Agents/Anti-Retroviral Agents/Anti-Retroviral Agents/*adverse effects ; Blood Glucose/Blood Glucose/Blood Glucose/*drug effects

  • Source: HIV clinical trials [HIV Clin Trials] 2008 Sep-Oct; Vol. 9 (5), pp. 314-23.Publisher: Taylor & Francis Country of Publication: England NLM ID: 100936377 Publication Model: Print Cited Medium: Print ISSN: 1528-4336

Record details

×
Academic Journal

Benfluorex as a therapeutic option for insulin resistance in HIV lipodystrophy syndrome.

  • Authors : Poizot-Martin I; CISIH-SUD, Clinical Research Department, Hôpital Sainte-Marguerite CHU, and INSERM U379, Marseille, France. ; Marimoutou C

Subjects: Insulin Resistance*; Fenfluramine/Fenfluramine/Fenfluramine/*analogs & derivatives ; Fenfluramine/Fenfluramine/Fenfluramine/*therapeutic use

  • Source: HIV clinical trials [HIV Clin Trials] 2004 Mar-Apr; Vol. 5 (2), pp. 86-90.Publisher: Taylor & Francis Country of Publication: England NLM ID: 100936377 Publication Model: Print Cited Medium: Print ISSN: 1528-4336

Record details

×
Academic Journal

Morphologic alterations in HIV-infected people with lipodystrophy are associated with good adherence to HAART.

  • Authors : Guaraldi G; Department of Medical and Surgery Specialities, infectious Diseases Clinic, University of Modena and Reggio Emilia School of Medicine, Italy. ; Murri R

Subjects: Patient Compliance*; Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*administration & dosage ; Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*adverse effects

  • Source: HIV clinical trials [HIV Clin Trials] 2003 Mar-Apr; Vol. 4 (2), pp. 99-106.Publisher: Taylor & Francis Country of Publication: England NLM ID: 100936377 Publication Model: Print Cited Medium: Print ISSN: 1528-4336

Record details

×
  • 1-10 of  25 results for ""HIV-associated lipodystrophy syndrome""